In vitro and invivo bioluminescent imaging to evaluate anti-Escherichia coli activity of Galla Chinensis

BioMedicine (Netherlands)

Volumn 3, Issue 4, 2013, Pages 160-166

  Ho, Tin Yun ^a   Lo, Hsin Yi ^a   Li, Chia Cheng ^a   Chen, Jaw Chyun ^b   Hsiang, Chien Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b DA YEH UNIVERSITY   (Taiwan)

Author keywords

Bioluminescent imaging; Escherichia coli; Galla Chinensis

Indexed keywords

ANTIINFECTIVE AGENT; GALLA CHINENSIS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL VIABILITY; BIOLUMINESCENCE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; GALLA CHINENSIS; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

EID: 84888875001     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2013.04.003     Document Type: Article

References (36)

1. Rice L.B. The clinical consequences of antimicrobial resistance. Curr Opin Microbiol 2009, 12:476-481.
2. Oteo J., Perez-Vazquez M., Campos J. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis 2010, 23:320-322.
3. Woodford N., Turton J.F., Livermore D.M. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011, 35:736-755.
4. van der Bij A.K., Pitout J.D. The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J Antimicrob Chemother 2012, 67:2090-2100.
5. Wong S.Y., Grant I.R., Friedman M., Elliott C.T., Situ C. Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis. Appl Environ Microbiol 2008, 74:5986-5990.
6. Zuo G.Y., Wang G.C., Zhao Y.B., Xu G.L., Hao X.Y., Han J., et al. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J Ethnopharmacol 2008, 120:287-290.
7. Saddiqe Z., Naeem I., Maimoona A. A review of the antibacterial activity of Hypericum perforatum L. J Ethnopharmacol 2010, 131:511-521.
8. Patel J.R., Tripathi P., Sharma V., Chauhan N.S., Dixit V.K. Phyllanthus amarus: ethnomedicinal uses, phytochemistry and pharmacology: a review. J Ethnopharmacol 2011, 138:286-313.
9. Salas V., Pastor F.J., Calvo E., Alvarez E., Sutton D.A., Mayayo E., et al. Invitro and invivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole. Antimicrob Agents Chemother 2012, 56:2246-2250.
10. Kong Y., Shi Y., Chang M., Akin A.R., Francis K.P., Zhang N., et al. Whole-body imaging of infection using bioluminescence. Curr Protoc Microbiol 2011, Chapter 2:Unit 2C.4.
11. Gonzalez R.J., Weening E.H., Frothingham R., Sempowski G.D., Miller V.L. Bioluminescence imaging to track bacterial dissemination of Yersinia pestis using different routes of infection in mice. BMC Microbiol 2012, 12:147.
12. Torres A.G., Cieza R.J., Rojas-Lopez M., Blumentritt C.A., Souza C.S., Johnston R.K., et al. Invivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infection. BMC Microbiol 2012, 12:112.
13. Guo Y., Ramos R.I., Cho J.S., Donegan N.P., Cheung A.L., Miller L.S. Invivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Antimicrob Agents Chemother 2013, 57:855-863.
14. Ho T.Y., Chen Y.S., Hsiang C.Y. Noninvasive nuclear factor-κB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice. Biomaterials 2007, 28:4370-4377.
15. Hsiang C.Y., Chen Y.S., Ho T.Y. Nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis for the assessment of host-biomaterial interaction invivo. Biomaterials 2009, 30:3042-3049.
16. Chang C.T., Lin H., Ho T.Y., Li C.C., Lo H.Y., Wu S.L., et al. Comprehensive assessment of host responses to ionizing radiation by nuclear factor-κB bioluminescence imaging-guided transcriptomic analysis. PLoS One 2011, 6. e23682.
17. Chang C.T., Ho T.Y., Lin H., Liang J.A., Huang H.C., Li C.C., et al. 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and invivo bioluminescence imaging. PLoS One 2012, 7. e31808.
18. Li C.C., Lo H.Y., Hsiang C.Y., Ho T.Y. DNA microarray analysis as a tool to investigate the therapeutic mechanisms and drug development of Chinese medicinal herbs. BioMedicine 2012, 2:10-16.
19. Li C.C., Hsiang C.Y., Wu S.L., Ho T.Y. Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis. Food Chem Toxicol 2012, 50:1568-1575.
20. Li C.C., Hsiang C.Y., Lo H.Y., Pai F.T., Wu S.L., Ho T.Y. Genipin inhibits lipopolysaccharide-induced acute systemic inflammation in mice as evidenced by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis. Food Chem Toxicol 2012, 50:2978-2986.
21. Hsiang C.Y., Hseu Y.C., Chang Y.C., Kumar K.J.S., Ho T.Y., Yang H.L. Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-κB transgenic mice, as evaluated by invivo bioluminescence imaging. Food Chem 2013, 136:426-434.
22. Djakpo O., Yao W. Rhus chinensis and Galla Chinensis - folklore to modern evidence: review. Phytother Res 2010, 24:1739-1747.
23. Chen J.C., Ho T.Y., Chang Y.S., Wu S.L., Hsiang C.Y. Anti-diarrheal effect of Galla Chinensis on the Escherichia coli heat-labile enterotoxin and ganglioside interaction. J Ethnopharmacol 2006, 103:385-391.
24. Cheng W.Y., Lien J.C., Hsiang C.Y., Wu S.L., Li C.C., Lo H.Y., et al. Comprehensive evaluation of a novel nuclear factor-κB inhibitor, quinoclamine, by transcriptomic analysis. Brit J Pharmacol 2009, 157:746-756.
25. Kadurugamuwa J.L., Sin L., Albert E., Yu J., Francis K., DeBoer M., et al. Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 2003, 71:882-890.
26. Xiong Y.Q., Willard J., Kadurugamuwa J.L., Yu J., Francis K.P., Bayer A.S. Real-time invivo bioluminescent imaging for evaluating the efficacy of antibiotics in a rat Staphylococcus aureus endocarditis model. Antimicrob Agents Chemother 2005, 49:380-387.
27. Jawhara S., Mordon S. Monitoring of bactericidal action of laser by invivo imaging of bioluminescent E. coli in a cutaneous wound infection. Lasers Med Sci 2006, 21:153-159.
28. Meletiadis J., Meis J.F., Mouton J.W., Donnelly J.P., Verweij P.E. Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) methods of invitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol 2000, 38:2949-2954.
29. Zhang L.N., Cao P., Tan S.H., Gu W., Shi L., Zhu H.L. Synthesis and antimicrobial activities of 7-O-modified genistein derivatives. Eur J Med Chem 2008, 43:1543-1551.
30. Pinto da Silva L., Esteves da Silva J.C. Firefly chemiluminescence and bioluminescence: efficient generation of excited states. Chemphyschem 2012, 13:2257-2262.
31. Xie Q., Li J., Zhou X. Anticaries effect of compounds extracted from Galla chinensis in a multispecies biofilm model. Oral Microbiol Immunol 2008, 23:459-465.
32. Cheng L., Exterkate R.A., Zhou X., Li J., ten Cate J.M. Effect of Galla chinensis on growth and metabolism of microcosm biofilms. Caries Res 2011, 45:87-92.
33. Ahn Y.J., Lee C.O., Kweon J.H., Ahn J.W., Park J.H. Growth-inhibitory effects of Galla Rhois-derived tannins on intestinal bacteria. J Appl Microbiol 1998, 84:439-443.
34. Bae E.A., Han M.J., Kim N.J., Kim D.H. Anti-Helicobacter pylori activity of herbal medicines. Biol Pharm Bull 1998, 21:990-992.
35. Choi J.G., Kang O.H., Lee Y.S., Oh Y.C., Chae H.S., Jang H.J., et al. Antibacterial activity of methyl gallate isolated from Galla Rhois or carvacrol combined with nalidixic acid against nalidixic acid resistant bacteria. Molecules 2009, 14:1773-1780.
36. Lee J.J., Bae J.H., Kim D.H., Lim J.J., Kim D.G., Lee H.J., et al. Intracellular replication inhibitory effects of Galla Rhois ethanol extract for Brucella abortus infection. J Ethnopharmacol 2011, 138:602-619.